Researchers aimed to identify a standardized practice for the early detection of cutaneous melanoma recurrence.

Interrupting DOAC therapy before surgery can increase the risk for thrombotic events, whereas continuing these medications can increase bleeding risk. Clinicians should adopt a balanced and ...

A meta-analysis of studies showed netupitant-palonosetron more effectively prevented CINV, particularly in the overall and delayed phases, compared with aprepitant.

Nearly half of patients with cancer experience some level of financial hardship (FH), according to a study published in JCO Oncology Practice. Betina Yanez, Ph.

The MammaPrint assay may be able to identify patients with HR+ early breast cancer who could benefit from extended letrozole therapy beyond 5 years, according to researchers.

Researchers sought to analyze deidentified sociodemographic and clinical data for children, adolescents, and young adults in the US who have cancer and COVID-19.

HealthDay News — For patients with breast cancer, moderate hypofractionation (MHF) shows an improved safety profile, cosmesis, and quality of life compared with conventional fractionation (CF), with ...

The 5-year disease-free survival rate was 84% in patients who received androgen deprivation therapy in combination with radiotherapy and 76% in patients who received radiotherapy alone. Combining ...

The hormone sensitivity of breast tissue makes it even more susceptible to damage from ionizing radiation from imaging ...

A total of 73 drug-drug interactions (DDIs) were detected, leading to discontinuation, therapeutic monitoring, oral anticancer therapy (OAT) change, OAT optimization, and/or dose adjustment.

The Food and Drug Administration (FDA) has granted traditional approval to Retevmo ® (selpercatinib) for adult and pediatric patients 2 years and older with advanced or metastatic medullary thyroid ...